Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 4, 2011, Pages 1087-1094

  Créhange, Gilles ^a   Parfait, Sébastien ^b   Liegard, Mélanie ^a   Maingon, Philippe ^a   Ben Salem, Douraïed ^c   Cochet, Alexandre ^c   Funes De La Vega, Mathilde ^c   Cormier, Luc ^c   Bonnetain, Franck ^a   Mirjolet, Céline ^a   Brunotte, Franois ^b,c   Walker, Paul M ^b,c  

^a CENTRE GEORGES FRANÇOIS LECLERC   (France)

^b CNRS   (France)

^c DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Biomarkers; Magnetic resonance spectroscopic imaging; Prostate cancer; Radiation oncology; Tumor volume

Indexed keywords

LOCALIZED PROSTATE CANCER; MAGNETIC RESONANCE SPECTROSCOPIC IMAGING; MAGNETIC RESONANCE SPECTROSCOPY IMAGING; MEAN AGES; MEAN RATIO; MEAN VALUES; ODDS RATIOS; PHASED ARRAY COILS; POLYAMINES; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; RADIATION ONCOLOGY; TUMOR VOLUME; TUMOR VOLUMES;

DISEASES; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; ONCOLOGY; TUMORS;

RADIOTHERAPY;

CHOLINE; CITRIC ACID; CREATINE; POLYAMINE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; CANCER DIAGNOSIS; CANCER LOCALIZATION; CONFERENCE PAPER; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; THREE DIMENSIONAL IMAGING; TUMOR VOLUME;

AGED; CHOLINE; CITRIC ACID; CREATINE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYAMINES; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 79959344957     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.03.007     Document Type: Conference Paper

References (45)

1. A. Jemal, R. Siegel, and E. Ward Cancer Statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. H. Grönberg Prostate cancer epidemiology Lancet 36 2003 859 864 (Pubitemid 36331852)
3. M. Mullerad, H. Hricak, and K. Kuroiwa Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer J Urol 174 2005 2158 2163 (Pubitemid 41611764)
4. M.D. Schnall, R.E. Lenkinski, and H.M. Pollack Prostate: MR imaging with an endorectal surface coil Radiology 172 1989 570 574 (Pubitemid 19184909)
5. S. Katz, and M. Rosen MR imaging and MR spectroscopy in prostate cancer management Radiol Clin North Am 44 2006 723 734 (Pubitemid 44498741)
6. M.D. Schnall, and H.M. Pollack Magnetic resonance imaging of the prostate gland Urol Radiol 12 1990 109 114 (Pubitemid 20373321)
7. M.R. Engelbrecht, G.J. Jager, and R.J. Laheij Local staging of prostate cancer using magnetic resonance imaging: A meta-analysis Eur Radiol 12 2002 2294 2302 (Pubitemid 36940327)
8. M. Fuchsjäger, O. Akin, and A. Shukla-Dave The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer Clin Adv Hematol Oncol 7 2009 193 202
9. 3) spatial resolution Radiology 198 1996 795 805 (Pubitemid 26066301)
10. K.K. Yu, J. Scheidler, and H. Hricak Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging Radiology 213 1999 481 488 (Pubitemid 29510596)
11. J. Scheidler, H. Hricak, and D.B. Vigneron Prostate cancer: Localization with three-dimensional proton MR spectroscopic imaging - clinicopathologic study Radiology 213 1999 473 480 (Pubitemid 29510595)
12. A.E. Wefer, H. Hricak, and D.B. Vigneron Sextant localization of prostate cancer: Comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology J Urol 164 2000 400 404 (Pubitemid 30481935)
13. J.C. Weinreb, J.D. Blume, and F.V. Coakley Prostate cancer: Sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy - Results of ACRIN prospective multi-institutional clinicopathologic study Radiology 251 2009 122 133
14. S.W. Heijmink, T.W. Scheenen, and E.N. van Lin Changes in prostate shape and volume and their implications for radiotherapy after introduction of endorectal balloon as determined by MRI at 3T Int J Radiat Oncol Biol Phys 73 2009 1446 1453
15. T.W. Scheenen, S.W. Heijmink, and S.A. Roell Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility Radiology 245 2007 507 516 (Pubitemid 47612533)
16. J. Sosna, I. Pedrosa, and W.C. Dewolf MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla Acad Radiol 11 2004 857 862 (Pubitemid 39006232)
17. M. Carlani, S. Mancino, and E. Bonanno Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: Preliminary experience Radiol Med 113 2008 670 688
18. A. Shukla-Dave, H. Hricak, and M.W. Kattan The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: An initial analysis BJU Int 99 2007 786 793 (Pubitemid 46439567)
19. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974 (Pubitemid 28445094)
20. J. Weis, H. Ahlstrom, and P. Hlavcak Two-dimensional spectroscopic imaging for pretreatment evaluation of prostate cancer: Comparison with the step-section histology after radical prostatectomy Magn Reson Imaging 27 2009 87 93
21. J.A. Jung, F.V. Coakley, and D.B. Vigneron Prostate depiction at endorectal MR spectroscopic imaging: Investigation of a standardized evaluation system Radiology 233 2004 701 708
22. A.A. Schricker, J.M. Pauly, and J. Kurhanewicz Dualband spectral-spatial RF pulses for prostate MR spectroscopic imaging Magn Reson Med 46 2001 1079 1087 (Pubitemid 33104295)
23. T.K. Tran, D.B. Vigneron, and N. Sailasuta Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer Magn Reson Med 43 2000 23 33 (Pubitemid 30027109)
24. M. Roach III, J. Kurhanewicz, and P. Carroll Spectroscopy in prostate cancer: Hope or hype? Oncology (Williston Park) 15 2001 1399 1410 (Pubitemid 33739250)
25. L. Kwock, J.K. Smith, and M. Castillo Clinical role of proton magnetic resonance spectroscopy in oncology: Brain, breast, and prostate cancer Lancet Oncol 7 2006 859 868 (Pubitemid 44464079)
26. G.M. Villeirs, W. Oosterlinck, and E. Vanherreweghe A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer Eur J Radiol 73 2010 352 356
27. J.J. Fütterer, S.W. Heijmink, and T.W. Scheenen Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging Radiology 241 2006 449 458 (Pubitemid 44632891)
28. C. Testa, R. Schiavina, and R. Lodi Prostate cancer: Sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT Radiology 244 2007 797 806 (Pubitemid 47292091)
29. F.H. Schröder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
30. C.H. Bangma, S. Roemeling, and F.H. Schröder Overdiagnosis and overtreatment of early detected prostate cancer World J Urol 25 2007 3 9
31. K.L. Blackwell, D.G. Bostwick, and R.P. Myers Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: The influence of prostate specific antigen cancer density J Urol 151 1994 1565 1570 (Pubitemid 24151303)
32. J.E. McNeal Cancer volume and site of origin of adenocarcinoma in the prostate: Relationship to local and distant spread Hum Pathol 23 1992 258 266
33. J.E. McNeal, D.G. Bostwick, and R.A. Kindrachuk Patterns of progression in prostate cancer Lancet 1 1986 60 63 (Pubitemid 16182890)
34. A.V. D'Amico, H. Chang, and E. Holupka Calculated prostate cancer volume: The optimal predictor of actual cancer volume and pathologic stage Urology 49 1997 385 391 (Pubitemid 27138681)
35. F.V. Coakley, J. Kurhanewicz, and Y. Lu Prostate cancer tumor volume: Measurement with endorectal MR and MR spectroscopic imaging Radiology 223 2002 91 97 (Pubitemid 34258194)
36. A.V. D'Amico, R. Whittington, and I. Kaplan Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter Cancer 82 1998 334 341 (Pubitemid 28060251)
37. K.L. Zakian, K. Sircar, and H. Hricak Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy Radiology 234 2005 804 814 (Pubitemid 40250824)
38. R.S. Brame, M. Zaider, and K.L. Zakian Regarding the focal treatment of prostate cancer: Inference of the Gleason grade from magnetic resonance spectroscopic imaging Int J Radiat Oncol Biol Phys 74 2009 110 114
39. T.H. van der Kwast, L. Collette, and H. Van Poppel Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911) Virchows Arch 449 2006 428 434 (Pubitemid 44451317)
40. T. Mizowaki, G.N. Cohen, and A.Y. Fung Towards integrating functional imaging in the treatment of prostate cancer with radiation: The registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning Int J Radiat Oncol Biol Phys 54 2002 1558 1564 (Pubitemid 35380063)
41. H.J. Huisman, J.J. Fütterer, and E.N. van Lin Prostate cancer: Precision of integrating functional MR imaging with radiation therapy treatment by using fiducial gold markers Radiology 236 2005 311 317 (Pubitemid 40853328)
42. M. Hirose, A. Bharatha, and N. Hata Quantitative MR imaging assessment of prostate gland deformation before and during MR imaging-guided brachytherapy Acad Radiol 9 2002 906 912 (Pubitemid 34856283)
43. A. Toledano, L. Chauveinc, and T. Flam PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: A study of 295 patients with a minimum 3-year followup Brachytherapy 5 2006 122 126
44. E.M. Horwitz, L.B. Levy, and H.D. Thames Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: A multiinstitutional pooled analysis Cancer 107 2006 1496 1502 (Pubitemid 44546909)
45. T. Joseph, D.A. McKenna, and A.C. Westphalen Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy Int J Radiat Oncol Biol Phys 73 2009 665 671